Could fixing cholesterol help save sight in diabetes?
NCT ID NCT03403686
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how a cholesterol-regulating protein called LXR might protect the eyes in people with diabetic retinopathy. Researchers will take blood samples from 104 adults with or without diabetes to test how certain blood cells function. The goal is to understand the biology better, not to test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new treatments for diabetic retinopathy by targeting cholesterol regulation.
- What could go wrong
- This is an early-stage observational study, not testing a treatment directly. Results may not lead to a therapy, and findings from lab tests may not translate to patient benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye doctor: could software catch diabetic blindness sooner?
- Can eye scans reveal hidden clues about diabetes damage?
- AI could predict which eye treatments work best for Diabetes-Related vision loss
- New eye drug aims to restore vision in Diabetes-Related swelling
- New eye drug aims to restore vision in Diabetes-Related swelling
- Eye scans could spot Diabetes-Related vision damage years early